BP
LEGN icon

BNP Paribas’s Legend Biotech LEGN Stock Holding History

BNP Paribas’s Portfolio LEGN Stock Details LEGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-3,556
Closed -$199K – 347
2024
Q1 		$199K Buy
+3,556
New +$214K 0.01% 232

Other funds holding LEGN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $832M AUM 32.38% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

BNP Paribas's LEGN Position: Q2 2024 in Review

BNP Paribas sold out of Legend Biotech (LEGN) in Q2 2024, closing a stake of 3,556 shares — an estimated $199K sold.

BNP Paribas first reported a position in LEGN in Q1 2024 and held it in 1 quarter. The position peaked at $199K in Q1 2024. 181 funds tracked by Wall St. Rank hold LEGN as of Q2 2024.

  • BNP Paribas reported no remaining Legend Biotech position as of Q2 2024 after selling out during the quarter.
  • BNP Paribas sold 3,556 Legend Biotech shares in Q2 2024, an estimated $199K.
  • BNP Paribas first reported a position in Legend Biotech in Q1 2024 and held it in 1 quarter.
  • BNP Paribas's Legend Biotech position peaked at $199K in Q1 2024.
  • 181 funds tracked by Wall St. Rank held Legend Biotech as of Q2 2024.

Based on BNP Paribas's 13F filing for Q2 2024, filed 13 Aug 2024.